Ladenburg Thalmann Financial Services’s Kite Pharma, Inc. KITE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,123	Closed	-$202K	–	5263
2017 Q3	$202K	Sell	1,123 -1,963	-64%	-$274K	﹤0.01%	2102
2017 Q2	$320K	Buy	3,086 +627	+25%	+$51.2K	﹤0.01%	1698
2017 Q1	$193K	Buy	2,459 +975	+66%	+$60.3K	﹤0.01%	1940
2016 Q4	$66K	Buy	1,484 +284	+24%	+$13.9K	﹤0.01%	2649
2016 Q3	$67K	Buy	1,200 +100	+9%	+$5.57K	﹤0.01%	2564
2016 Q2	$55K	Buy	1,100 +200	+22%	+$9.83K	﹤0.01%	2607
2016 Q1	$41K	Buy	900 +100	+13%	+$4.84K	﹤0.01%	2749
2015 Q4	$49K	Buy	800 +125	+19%	+$8.8K	﹤0.01%	2578
2015 Q3	$38K	Buy	675 +575	+575%	+$36.2K	﹤0.01%	2664
2015 Q2	$6K	Sell	100 -147	-60%	-$8.39K	﹤0.01%	4009
2015 Q1	$14K	Buy	+247	New	+$16.6K	﹤0.01%	3434

Ladenburg Thalmann Financial Services's KITE Position: Q4 2017 in Review

Ladenburg Thalmann Financial Services sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,123 shares — an estimated $202K sold.

Ladenburg Thalmann Financial Services first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $320K in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Ladenburg Thalmann Financial Services reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 1,123 Kite Pharma, Inc. shares in Q4 2017, an estimated $202K.
Ladenburg Thalmann Financial Services first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
Ladenburg Thalmann Financial Services's Kite Pharma, Inc. position peaked at $320K in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2017, filed 14 Feb 2018.